"Cannabidiol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compound isolated from Cannabis sativa extract.
| Descriptor ID |
D002185
|
| MeSH Number(s) |
D02.455.849.090.100
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cannabidiol".
Below are MeSH descriptors whose meaning is more specific than "Cannabidiol".
This graph shows the total number of publications written about "Cannabidiol" by people in this website by year, and whether "Cannabidiol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2018 | 3 | 0 | 3 |
| 2019 | 4 | 2 | 6 |
| 2020 | 0 | 1 | 1 |
| 2021 | 4 | 0 | 4 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cannabidiol" by people in Profiles.
-
Cannabinoid use is enhanced by stress and changes conditioned stress responses. Neuropsychopharmacology. 2022 04; 47(5):1037-1045.
-
A scoping review of the use of cannabidiol in psychiatric disorders. Psychiatry Res. 2022 02; 308:114347.
-
Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 10; 62(10):2505-2517.
-
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 09; 62(9):2228-2239.
-
Cannabinoid Receptor Activation on Haematopoietic Cells and Enterocytes Protects against Colitis. J Crohns Colitis. 2021 Jun 22; 15(6):1032-1048.
-
Long Noncoding RNA AW112010 Promotes the Differentiation of Inflammatory T Cells by Suppressing IL-10 Expression through Histone Demethylation. J Immunol. 2020 08 15; 205(4):987-993.
-
The effects of chronic ?-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) use on cerebral glucose metabolism in multiple sclerosis: a pilot study. Appl Physiol Nutr Metab. 2020 Apr; 45(4):450-452.
-
The loss of NMDAR-dependent LTD following cannabinoid self-administration is restored by positive allosteric modulation of CB1 receptors. Addict Biol. 2020 11; 25(6):e12843.
-
Cannabidiol Regulates Gene Expression in Encephalitogenic T cells Using Histone Methylation and noncoding RNA during Experimental Autoimmune Encephalomyelitis. Sci Rep. 2019 10 31; 9(1):15780.
-
Combination of Cannabinoids, ?9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways. Front Immunol. 2019; 10:1921.